Location: New York, NY
CIK: 0002054410 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $295M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TERN | TERNS PHARMACEUTICALS INC | 1,746,264 | $70.55M | 23.9% | $6.77 | +241.3% | COM | 880881107 |
| CGON | CG ONCOLOGY INC | 1,131,501 | $46.98M | 15.9% | $34.21 | +21.0% | COM | 156944100 |
| URGN | UROGEN PHARMA LTD | 1,448,420 | $33.92M | 11.5% | $13.24 | +63.9% | COM | M96088105 |
| TRVI | TREVI THERAPEUTICS INC | 2,144,844 | $26.85M | 9.1% | $3.31 | +249.6% | COM | 89532M101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 4,131,299 | $24.58M | 8.3% | $2.92 | +81.7% | COM | 74587V107 |
| CADL | CANDEL THERAPEUTICS INC | 2,580,517 | $14.58M | 4.9% | $5.97 | -9.9% | COM | 137404109 |
| HELP | CYBIN INC | 1,573,023 | $12.87M | 4.4% | $8.17 | -21.2% | COM NEW | 23256X407 |
| VSTM | VERASTEM INC | 1,469,153 | $11.34M | 3.8% | $6.27 | +42.1% | COM | 92337C203 |
| BCAX | BICARA THERAPEUTICS | 643,382 | $10.83M | 3.7% | $20.81 | -17.9% | COM | 055477103 |
| TARA | PROTARA THERAPEUTICS INC | 1,752,115 | $9.339M | 3.2% | $3.29 | +69.0% | COM STK | 74365U107 |
| OKUR | ONKURE THERAPEUTICS INC | 2,839,674 | $8.235M | 2.8% | $8.97 | -66.6% | CLASS A COM | 68277Q105 |
| CRDF | CARDIF ONCOLOGY INC | 1,962,084 | $5.513M | 1.9% | $3.02 | -23.2% | COM | 14147L108 |
| LONA | ATHIRA PHARMA INC. | 501,739 | $3.798M | 1.3% | $4.58 | 0.0% | COMMON STOCK | 04746L203 |
| JSPR | JASPER THERAPEUTICS | 1,786,492 | $3.269M | 1.1% | $2.80 | -28.3% | COM | 471871202 |
| AURA | AURA BIOSCIENCES INC | 595,744 | $3.247M | 1.1% | $7.57 | -21.5% | COM | 05153U107 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 1,139,363 | $2.757M | 0.9% | $2.27 | +1.3% | COM | 00032Q104 |
| BCAB | BIOATLA INC | 4,835,111 | $2.756M | 0.9% | $1.47 | -46.6% | COM | 09077B104 |
| QTTB | Q32 BIO INC. | 493,425 | $1.638M | 0.6% | $31.58 | -91.0% | COM | 746964105 |
| — | X4 PHARMACEUTICALS INC | 273,349 | $1.093M | 0.4% | $1.91 | — | COM | 98420X103 |
| ACRV | ACRIVON THERAPEUTICS INC | 405,237 | $977K | 0.3% | $7.27 | -70.1% | COMMON STOCK | 004890109 |
| VYNE | VYNE THERAPEUTICS INC | 1,425 | $827 | 0.0% | $2.55 | -84.3% | COM | 92941V308 |